O&O Alpan
Fairfax, Virginia 22031
We've found
7 trials
at this facility
Fabry Disease Clinical Trial
Updated: 12/31/1969
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Neurology, Pharmacology / Toxicology Clinical Trial
Updated: 4/3/2017
Investigating Lysosomal Storage Diseases in Minority Groups
Status: Enrolling
Updated: 4/3/2017
Click here to add this to my saved trials
Allergy Clinical Trial
Updated: 11/9/2015
Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America
Status: Enrolling
Updated: 11/9/2015
Click here to add this to my saved trials
Type 1 Gaucher Disease Clinical Trial
Updated: 12/31/1969
Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Updated: 12/31/1969
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pompe Disease Clinical Trial
Updated: 11/25/2013
Pregnancy and Birth Outcome in Women With Pompe Disease
Status: Enrolling
Updated: 11/25/2013
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Updated: 12/31/1969
Extension Study of 1 mg/kg Pegunigalsidase Alfa in Patients With Fabry Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials